A Study of Darunavir in the Presence of Cobicistat When Administered as a Fixed Dose Combination Compared to the Co-administration of the Separate Available Formulations of Darunavir and Cobicistat Under Fed Conditions in Healthy Participants
Clinical trial NCT05378906 · COMPLETED
Trial details
- NCT number
- NCT05378906
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-07
- Primary completion
- 2022-09-28
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.